LSD1 Antibody (F41980)
 Catalog No.  Formulation  Size
F41980-0.4ML
In 1X PBS, pH 7.4, with 0.09% sodium azide
0.4 ml
F41980-0.08ML
In 1X PBS, pH 7.4, with 0.09% sodium azide
0.08 ml
./plp/all_image/img-F41980-0.4ML-1.jpg ./plp/all_image/img-F41980-0.4ML-2.jpg ./plp/all_image/img-F41980-0.4ML-3.jpg ./plp/all_image/img-F41980-0.4ML-4.jpg
Bulk quote request
Availability 1-3 business days
Species Reactivity Human
Predicted Reactivity Mouse
Format Purified
Host Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Purity Purified
UniProt O60341
Applications Western Blot : 1:1000
IHC (Paraffin) : 1:50-1:100
Immunofluorescence : 1:10-1:50
Limitations This LSD1 antibody is available for research use only.
Western blot testing of LSD1 antibody and nuclear extracts of control and PhIP-treated HMEC cells. Nuclear LSD1 protein levels increased in carcinogen-treated HMEC compared with control HMEC.
Western blot testing of LSD1 antibody and nuclear extracts of control and PhIP-treated HMEC cells. Nuclear LSD1 protein levels increased in carcinogen-treated HMEC compared with control HMEC.
Western blot analysis of LSD1 antibody and 293 cell lysate either nontransfected (Lane 1) or transiently transfected with the AOF2 gene (2). Expected molecular weight ~110kDa.
Western blot analysis of LSD1 antibody and 293 cell lysate either nontransfected (Lane 1) or transiently transfected with the AOF2 gene (2). Expected molecular weight ~110kDa.
Fluorescent confocal image of HeLa cell stained with LSD1 antibody. LSD1 immunoreactivity is localized to the nucleus.
Fluorescent confocal image of HeLa cell stained with LSD1 antibody. LSD1 immunoreactivity is localized to the nucleus.
IHC analysis of FFPE human hepatocarcinoma stained with the LSD1 antibody
IHC analysis of FFPE human hepatocarcinoma stained with the LSD1 antibody